Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q96T75-5 DSCR8
| Class:Id | ReferenceIsoform:9027698 |
|---|---|
| _displayName | UniProt:Q96T75-5 DSCR8 |
| _timestamp | 2023-11-03 17:59:06 |
| chain | chain:1-97 |
| checksum | 6A59E035E03285C4 |
| comment | INTERACTION Expressed in numerous tissues; not found in breast, heart, small intestine and liver (PubMed:12036297). Isoform 1: Predominantly expressed in the testis (PubMed:11920614, PubMed:15472897). Isoform 3: Predominantly expressed in the testis, at lower level in the placenta, during malignant progression of melanocytic tumors and in several tumors of varying origins (PubMed:11920614, PubMed:15472897). Isoform 4: Predominantly expressed in the testis, at lower level in the placenta, during malignant progression of melanocytic tumors and in several tumors of varying origins (PubMed:11920614, PubMed:15472897). Isoform 5: Predominantly expressed in the testis (PubMed:11920614, PubMed:15472897). Isoform 6: Predominantly expressed in the testis (PubMed:11920614, PubMed:15472897).MISCELLANEOUS Potential cancer-testis antigen, with expression restricted to the testis and certain malignant cells.MISCELLANEOUS Predominantly expressed in the testis.MISCELLANEOUS Predominantly expressed in the testis, at lower level in the placenta, during malignant progression of melanocytic tumors and in several tumors of varying origins.MISCELLANEOUS Predominantly expressed in the testis, at lower level in the placenta, during malignant progression of melanocytic tumors and in several tumors of varying origins.MISCELLANEOUS Predominantly expressed in the testis.MISCELLANEOUS Predominantly expressed in the testis. |
| created | [InstanceEdit:9027688] Weiser, JD |
| description | recommendedName: fullName evidence="5"Down syndrome critical region protein 8 alternativeName: Cancer/testis antigen 25 shortName: CT25 alternativeName: fullName evidence="6"DCR1-24.0 alternativeName: fullName evidence="4 7"Malignant melanoma-associated protein 1 shortName evidence="4 7"MMA-1 alternativeName: Protein MTAG2 |
| geneName | DSCR8 C21orf65 MTAG2 |
| identifier | Q96T75 |
| isoformParent | |
| isSequenceChanged | FALSE |
| keyword | Alternative splicing Reference proteome |
| modified | [InstanceEdit:9037114] Weiser, JD [InstanceEdit:9637257] Weiser, JD [InstanceEdit:9676415] Weiser, JD [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 |
| name | DSCR8 |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:8991821] ENSEMBL:ENSG00000198054 DSCR8 [Homo sapiens] |
| secondaryIdentifier | DSCR8_HUMAN Q684H4 Q6EXA9 Q8N3X0 Q8NDY5 Q96B46 |
| sequenceLength | 97 |
| species | [Species:48887] Homo sapiens |
| variantIdentifier | Q96T75-5 |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q96T75-5 DSCR8 (9027698)
